Back to Results
First PageMeta Content
Patent infringement / United States patent law / Phentermine/topiramate / Patent / Generic drug / Actavis / Food and Drug Administration / Pharmaceutical sciences / Pharmacology / Medicine


Case 2:14-cv[removed]FSH-MAH Document 1 Filed[removed]Page 1 of 16 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520
Add to Reading List

Document Date: 2014-06-25 04:57:47


Open Document

File Size: 189,60 KB

Share Result on Facebook

City

Dublin / Parsippany / Mountain View / /

Company

NEW JERSEY VIVUS INC. / ACTAVIS LABORATORIES FL INC. / ACTAVIS INC. / Plaintiff VIVUS Inc. / VIVUS / Interpace / Actavis plc. / Actavis Laboratories / Inc. / Lizza William C. Baton SAUL EWING LLP / /

Country

United States / Ireland / /

/

Event

Patent Issuance / FDA Phase / Legal Issues / /

Facility

Grand Canal Square / Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza / /

IndustryTerm

pharmaceutical compositions containing combinations / active pharmaceutical ingredients / pharmaceutical products / drug products / /

MedicalCondition

obesity / /

Organization

United States Patent and Trademark Office / United States Food and Drug Administration / /

Person

Leland F. Wilson / Thomas Najarian / Peter Y. Tam / /

/

Product

topiramate / QSYMIA® / /

ProvinceOrState

New Jersey / Nevada / Delaware / Florida / California / New / /

SocialTag